These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3718541)

  • 21. Partial inhibition of hepatic microsomal aminopyrine N-demethylase by caffeine in partially purified cytochrome P450.
    Govindwar SP; Kachole MS; Pawar SS
    Biochim Biophys Acta; 1983 Mar; 756(2):191-5. PubMed ID: 6830852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of hepatic mixed function oxidases--II. Some benzimidazole, benzoxazole and benzothiazole derivatives.
    Holder GM; Little PJ; Ryan AJ; Watson TR
    Biochem Pharmacol; 1976 Dec; 25(24):2747-50. PubMed ID: 1008898
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of hepatic drug metabolism by phenothiazine tranquilizers: quantitative structure-activity relationships and selective inhibition of cytochrome P-450 isoform-specific activities.
    Murray M
    Chem Res Toxicol; 1989; 2(4):240-6. PubMed ID: 2577523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ethoxyquin on the carbon tetrachloride-induced changes in rat hepatic microsomal enzymes.
    Cawthorne MA; Palmer ED; Green J
    Biochem Pharmacol; 1973 Aug; 22(16):2066-8. PubMed ID: 4353671
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction of the substrate analogue of cytochrome P-450 and mixed function oxidases.
    Popova VI; Leonova IN; Weiner LM; Salganik RI
    Biochem Pharmacol; 1982 Jun; 31(11):1993-8. PubMed ID: 6288047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of hepatic microsomal enzymes by gossypol in the rat.
    Ma XN; Back DJ
    Contraception; 1984 Jul; 30(1):89-97. PubMed ID: 6478834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone.
    Chapman DE; Holbrook DJ; Chaney SG; Hall IH; Lee KH
    Biochem Pharmacol; 1989 Nov; 38(22):3913-23. PubMed ID: 2512929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine inhibition of mixed function oxidase activity in rat and human liver microsomes and in the isolated perfused rat liver.
    Morris CQ; Tucker GT; Crewe HK; Harlow JR; Woods HF; Lennard MS
    Biochem Pharmacol; 1989 Aug; 38(16):2639-44. PubMed ID: 2764987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of benznidazole on the mixed function oxygenase system from rat liver microsomes.
    Masana M; de Toranzo EG; Rubio M; Castro JA
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):4-11. PubMed ID: 4051638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
    Hargreaves MB; Jones BC; Smith DA; Gescher A
    Drug Metab Dispos; 1994; 22(5):806-10. PubMed ID: 7835233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF; Mehta I; Murray M
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic aminopyrine N-demethylase system: interaction of aminopyrine with microsomal cytochrome P-450.
    Hachino Y; Matsubara T; Hagihara B
    Jpn J Pharmacol; 1981 Dec; 31(6):911-20. PubMed ID: 7334736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug metabolism and drug-induced spectral interactions in human fetal liver microsomes.
    Pelkonen O
    Biochem Pharmacol; 1973 Oct; 22(19):2357-64. PubMed ID: 4147669
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of the inhibitory action of phenelzine on microsomal drug metabolism.
    Muakkassah SF; Yang WC
    J Pharmacol Exp Ther; 1981 Oct; 219(1):147-55. PubMed ID: 7288604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General anesthetics inhibit cytochrome P450 monooxygenases and arachidonic acid metabolism.
    LaBella FS; Queen G
    Can J Physiol Pharmacol; 1993 Jan; 71(1):48-53. PubMed ID: 8513433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450.
    Babany G; Tinel M; Letteron P; Freneaux E; Berson A; Larrey D; Pessayre D
    Biochem Pharmacol; 1989 Mar; 38(6):941-7. PubMed ID: 2930595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatic mixed function oxidase activity by propyl gallate.
    Yang CS; Strickhart FS
    Biochem Pharmacol; 1974 Nov; 23(22):3129-38. PubMed ID: 4155301
    [No Abstract]   [Full Text] [Related]  

  • 38. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of inhibition by carbonyl cyanide m-chlorophenylhydrazone and sodium deoxycholate of cytochrome P-450-catalysed hepatic microsomal drug metabolism.
    Tsyrlov IB; Gromova OA; Lyakhovich VV
    Biochem J; 1976 Oct; 160(1):75-83. PubMed ID: 12746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paracetamol, 3-monoalkyl- and 3,5-dialkyl derivatives. Comparison of their microsomal cytochrome P-450 dependent oxidation and toxicity in freshly isolated hepatocytes.
    Van De Straat R; De Vries J; Kulkens T; Debets AJ; Vermeulen NP
    Biochem Pharmacol; 1986 Nov; 35(21):3693-9. PubMed ID: 3778500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.